Wave Life Sciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $17,245 | $7,608 | $8,699 | $9,175 |
Gross Profit | 14,983 | 7,608 | 6,503 | 7,011 |
EBITDA | -50,917 | -51,622 | -50,563 | -47,640 |
EBIT | -53,179 | -53,852 | -52,759 | -49,804 |
Net Income | -53,179 | -53,852 | -50,469 | -46,878 |
Net Change In Cash | 17,245 | 7,608 | 8,699 | 9,175 |
Free Cash Flow | -32,113 | -44,914 | -46,318 | -63,204 |
Cash | 602,068 | 196,218 | 208,481 | 243,075 |
Basic Shares | 180,152 | 167,739 | 163,987 | 162,527 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $42,727 | $108,302 | $113,305 | $3,649 |
Gross Profit | 33,875 | 108,302 | 113,305 | 3,649 |
EBITDA | -195,526 | -101,740 | -58,790 | -152,606 |
EBIT | -204,378 | -110,403 | -67,996 | -162,720 |
Net Income | -204,378 | -97,008 | -57,513 | -161,823 |
Net Change In Cash | 42,727 | 108,302 | 113,305 | 3,649 |
Cost of Revenue | -61,848 | |||
Free Cash Flow | -187,493 | -151,964 | -20,546 | -129,142 |
Cash | 602,068 | 302,078 | 200,351 | 88,497 |
Basic Shares | 168,649 | 138,277 | 106,097 | 78,855 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.30 |
2025-09-30 | -$0.32 |
2025-06-30 | -$0.31 |
